SuperworthImmunic shares outstanding IMUX
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 42.5M
- On a year earlier
- +221.6%
- more shares
Immunic had 42.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 221.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 19.4M | +93% |
| FY2024 | 10.1M | +126% |
| FY2023 | 4.5M | +17% |
| FY2022 | 3.8M | +28% |
| FY2021 | 3M | +44% |
| FY2020 | 2.1M | +103% |
| FY2019 | 1M | +1107% |
| FY2018 | 84.7K | −20% |
| FY2017 | 105.6K | +32% |
| FY2016 | 80.2K | +12% |
| FY2015 | 71.4K | +21% |
| FY2014 | 59.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 42.5M | +222% | |
| Q1 FY26 | 30.1M | +197% | |
| Q4 FY25 | 19.4M | +93% | |
| Q3 FY25 | 19.4M | +91% | |
| Q2 FY25 | 13.2M | +31% | |
| Q1 FY25 | 10.1M | +4% | |
| Q4 FY24 | 10.1M | +126% | |
| Q3 FY24 | 10.1M | +127% | |
| Q2 FY24 | 10.1M | +128% | |
| Q1 FY24 | 9.7M | +123% | |
| Q4 FY23 | 4.5M | +17% | |
| Q3 FY23 | 4.5M | +46% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Immunic
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.